Spots Global Cancer Trial Database for aromatase inhibitors
Every month we try and update this database with for aromatase inhibitors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer | NCT00908531 | Operable Breast... | letrozole (Fema... | 60 Years - | Danish Breast Cancer Cooperative Group | |
| Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors | NCT03712813 | Breast Cancer | Macrodyne LivMD... | 18 Years - | Indiana University | |
| Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients | NCT02511639 | Breast Cancer M... | Everolimus Aromatase Inhib... | 18 Years - | Istituto Oncologico Veneto IRCCS | |
| Hemostatic Profiles of Endocrine Therapies for Breast Cancer | NCT03381963 | Breast Neoplasm... Venous Thromboe... | 18 Years - | University Hospital, Geneva | ||
| Targeted Physiotherapeutic Treatment for Aromatase Inhibitor-associated Musculoskeletal Pain in Breast Cancer Survivors | NCT04560699 | Musculoskeletal... | Physiotherapeut... medical care | 18 Years - | Frederiksberg University Hospital | |
| Assessment of Cryotherapy's Analgesic Impact in Anti-aromatase-induced Arthralgia | NCT05315011 | Breast Cancer Aromatase Inhib... | Whole-body cryo... Placebo cryothe... | 18 Years - | University Hospital, Montpellier | |
| Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients | NCT01530373 | Hot Flashes Breast Cancer | solifenacin Clonidine | 18 Years - | University of Arkansas | |
| Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS) | NCT03624244 | Low Grade Endom... | Aromatase Inhib... | 18 Years - | Centre Leon Berard | |
| Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors | NCT01758146 | Breast Cancer | Tamoxifen Letrozole | 45 Years - 80 Years | PGIMER | |
| Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women | NCT02914158 | Breast Cancer | Goserelin Tamoxifen Aromatase Inhib... Leuprolide | - 35 Years | First Affiliated Hospital, Sun Yat-Sen University | |
| Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer | NCT02910050 | Breast Cancer | Bicalutamide Aromatase Inhib... | 18 Years - 80 Years | Sun Yat-sen University | |
| Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7) | NCT04227327 | Advanced Breast... | Abemaciclib Aromatase Inhib... | 18 Years - | University of Milano Bicocca | |
| Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer | NCT04460807 | Ovarian Cancer | Exemestane Placebo oral ta... | 18 Years - | Ente Ospedaliero Ospedali Galliera | |
| An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice | NCT00767585 | Breast Cancer Osteoporosis | 55 Years - 65 Years | AstraZeneca | ||
| Progressive Relaxation Training in Breast Cancer Patients Receiving Aromatatase Inhibitor Therapy | NCT04163692 | Breast Cancer | Progressive rel... | 30 Years - 70 Years | Hacettepe University | |
| PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer | NCT00508586 | Metastatic Brea... | PTC299 | 18 Years - | PTC Therapeutics | |
| Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer | NCT01484041 | Breast Cancer | Dovitinib Aromatase Inhib... | 18 Years - | Georgetown University | |
| Stellate Ganglion Block (SGB) For Women for Breast Cancer | NCT02513329 | Hot Flushes Hot Flashes | Bupivicaine Saline | 30 Years - 70 Years | Northwestern University | |
| Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms | NCT05637671 | Vasomotor Sympt... | oxybutynin ER Paroxetine CR | - | Cairo University | |
| Hemostatic Profiles of Endocrine Therapies for Breast Cancer | NCT03381963 | Breast Neoplasm... Venous Thromboe... | 18 Years - | University Hospital, Geneva | ||
| Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN) | NCT04240106 | Breast Cancer Breast Cancer M... | Niraparib Aromatase Inhib... | 18 Years - | MedSIR | |
| Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer | NCT04047758 | Breast Cancer | Palbociclib + L... Letrozole | 18 Years - 70 Years | Shengjing Hospital | |
| Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer | NCT04047758 | Breast Cancer | Palbociclib + L... Letrozole | 18 Years - 70 Years | Shengjing Hospital | |
| A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms | NCT02874222 | Breast Cancer | surveys complet... | 18 Years - 60 Years | United States Naval Medical Center, San Diego | |
| A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors and Tamoxifen | NCT01223833 | Breast Cancer Arthralgia | 18 Years - | Universitaire Ziekenhuizen KU Leuven | ||
| Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women | NCT01793038 | Polycystic Ovar... Infertility | Aromatase inhib... clomiphene citr... | 18 Years - 38 Years | Mansoura Integrated Fertility Center | |
| Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women | NCT01793038 | Polycystic Ovar... Infertility | Aromatase inhib... clomiphene citr... | 18 Years - 38 Years | Mansoura Integrated Fertility Center | |
| Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) | NCT00712985 | Breast Cancer | Zometa | 18 Years - | Milton S. Hershey Medical Center | |
| Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer | NCT05264649 | Arthralgia | acupuncture Guizhi-Shaoyao-... | 20 Years - 90 Years | Show Chwan Memorial Hospital | |
| Adjuvant Post-Tamoxifen Exemestane Trial | NCT00810706 | Breast Cancer | exemestane | 18 Years - 80 Years | Hellenic Breast Surgeons Society | |
| Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy | NCT01697345 | Breast Cancer Vaginal Dryness Dyspareunia Sexual Health Q... | Testosterone | 50 Years - | Creighton University | |
| Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women | NCT02914158 | Breast Cancer | Goserelin Tamoxifen Aromatase Inhib... Leuprolide | - 35 Years | First Affiliated Hospital, Sun Yat-Sen University | |
| Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer | NCT02769104 | Neoadjuvant The... | Letrozole (Arom... AC*4-T*4 | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients | NCT01983995 | Breast Cancer | 50 Years - | University of Michigan | ||
| Overcoming Endocrine Resistance in Metastatic Breast Cancer | NCT02394496 | Metastatic Brea... | Fulvestrant Lapatinib Aromatase Inhib... Placebo Lapatin... | 18 Years - | Consorzio Oncotech | |
| Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN) | NCT04240106 | Breast Cancer Breast Cancer M... | Niraparib Aromatase Inhib... | 18 Years - | MedSIR | |
| A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer | NCT01216176 | Breast Cancer | Anastrozole AZD0530 (saraca... Placebo | 18 Years - | University of Miami | |
| PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer | NCT00508586 | Metastatic Brea... | PTC299 | 18 Years - | PTC Therapeutics | |
| Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors | NCT00738998 | Breast Cancer | Questionnaire Phone Calls | 18 Years - | M.D. Anderson Cancer Center | |
| Arimidex Bone Mass Index and Oral Bisphosphonates | NCT00809484 | Breast Cancer Bone Density | 18 Years - 80 Years | Hellenic Breast Surgeons Society | ||
| Aromatase Inhibitor Host Factors Study | NCT01669343 | Breast Neoplasm... | Letrozole | - | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | |
| Alcohol and Breast Cancer (ABC) Trial | NCT05423730 | ER+ Breast Canc... Breast Cancer Aromatase Inhib... | White Wine Grape Juice | 21 Years - 90 Years | Beth Israel Deaconess Medical Center | |
| Overcoming Endocrine Resistance in Metastatic Breast Cancer | NCT02394496 | Metastatic Brea... | Fulvestrant Lapatinib Aromatase Inhib... Placebo Lapatin... | 18 Years - | Consorzio Oncotech | |
| Acupuncture for Aromatase Inhibitor Induced Joint Pain | NCT00826397 | Breast Cancer | Acupuncture Sham Acupunctur... | 45 Years - | Columbia University | |
| Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy | NCT06172088 | Breast Cancer P... | Fasting | 18 Years - 70 Years | University Hospital Tuebingen | |
| Assessment of Cryotherapy's Analgesic Impact in Anti-aromatase-induced Arthralgia | NCT05315011 | Breast Cancer Aromatase Inhib... | Whole-body cryo... Placebo cryothe... | 18 Years - | University Hospital, Montpellier | |
| Genetic Predictors to Acupuncture Response for Arthralgia Induced by Aromatase Inhibitors in Patients With Breast Cancer | NCT05125432 | Breast Cancer | Acupuncture gro... | 18 Years - 75 Years | Affiliated Hospital of Qinghai University | |
| Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence | NCT02657993 | Breast Neoplasm... Musculoskeletal... | Hypnosis Attention Contr... | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies | NCT03898947 | Breast Cancer Endometrial Can... | Diagnostic hyst... | 18 Years - 80 Years | Università degli Studi dell'Insubria | |
| Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer | NCT00702858 | Breast Cancer Joint Pain | Blue Citrus Placebo | 18 Years - | Legacy Health System | |
| Breast Cancer Women on Aromatase Inhibitors Treatment | NCT03811509 | Osteoporosis Osteoporosis Fr... Arthralgia Gene... | bisphosphonate | 40 Years - 80 Years | Parc de Salut Mar | |
| Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer | NCT02769104 | Neoadjuvant The... | Letrozole (Arom... AC*4-T*4 | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women | NCT01793038 | Polycystic Ovar... Infertility | Aromatase inhib... clomiphene citr... | 18 Years - 38 Years | Mansoura Integrated Fertility Center | |
| A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms | NCT02874222 | Breast Cancer | surveys complet... | 18 Years - 60 Years | United States Naval Medical Center, San Diego | |
| HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer | NCT03111615 | Hormone Depende... Breast Cancer F... | Aromatase Inhib... | 50 Years - | Centro Hospitalar Lisboa Ocidental | |
| Health and QoL in Oncological Patients: Management of Bone Pathology in Italian Citbl Population | NCT04055805 | Breast Cancer F... Osteoporosis | Observational A... | 18 Years - 75 Years | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer | NCT02820961 | Breast Cancer Estrogen Recept... | entinostat exemestane | 18 Years - 85 Years | Syndax Pharmaceuticals | |
| Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors | NCT02406794 | Breast Neoplasm... | Neuromuscular t... | 18 Years - | University of Malaga | |
| Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer | NCT02769104 | Neoadjuvant The... | Letrozole (Arom... AC*4-T*4 | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| Stellate Ganglion Block (SGB) For Women for Breast Cancer | NCT02513329 | Hot Flushes Hot Flashes | Bupivicaine Saline | 30 Years - 70 Years | Northwestern University | |
| Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients | NCT02511639 | Breast Cancer M... | Everolimus Aromatase Inhib... | 18 Years - | Istituto Oncologico Veneto IRCCS | |
| Cognitive Sequelae of Adjuvant Endocrine Therapy for the Treatment of Breast Cancer in Older Women | NCT02480218 | Breast Cancer | Neuropsychologi... | 65 Years - | Sunnybrook Health Sciences Centre | |
| Stellate Ganglion Block (SGB) For Women for Breast Cancer | NCT02513329 | Hot Flushes Hot Flashes | Bupivicaine Saline | 30 Years - 70 Years | Northwestern University | |
| Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors | NCT00738998 | Breast Cancer | Questionnaire Phone Calls | 18 Years - | M.D. Anderson Cancer Center | |
| Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) | NCT00712985 | Breast Cancer | Zometa | 18 Years - | Milton S. Hershey Medical Center | |
| Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer | NCT04088110 | Breast Cancer F... HER2-positive B... Hormone Recepto... Metastatic Brea... Breast Diseases Hormone Recepto... | Pyrotinib Trastuzumab Aromatase Inhib... | 18 Years - 70 Years | Fuzhou General Hospital | |
| Trial of Perioperative Endocrine Therapy - Individualising Care | NCT02338310 | Breast Cancer | Aromatase Inhib... | 50 Years - | Institute of Cancer Research, United Kingdom | |
| The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins | NCT01341171 | Breast Cancer | 18 Years - | University of Vermont | ||
| Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy | NCT00485953 | Bone Loss Osteoporosis Breast Cancer | risedronate | 55 Years - | University of Pittsburgh | |
| 10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI) | NCT00885612 | Breast Cancer | 50 Years - | AstraZeneca | ||
| Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. | NCT01122342 | Vaginitis Dyspareunia Breast Neoplasm... | Testosterone pr... | 18 Years - | University of Vermont | |
| Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer | NCT02769104 | Neoadjuvant The... | Letrozole (Arom... AC*4-T*4 | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer | NCT04352777 | Metastatic Brea... Locally Advance... Hormone Recepto... | Abemaciclib Fulvestrant Aromatase Inhib... | 18 Years - | Duke University | |
| Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors | NCT01758146 | Breast Cancer | Tamoxifen Letrozole | 45 Years - 80 Years | PGIMER | |
| Aromatase Inhibitor Host Factors Study | NCT01669343 | Breast Neoplasm... | Letrozole | - | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | |
| Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors | NCT04651452 | Breast Cancer | Value Affirmati... Reflective Jour... | 18 Years - | Carnegie Mellon University | |
| CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI) | NCT00973505 | Breast Neoplasm... Arthralgia Arthritis Genetic Polymor... | Aromatase Inhib... | 18 Years - 80 Years | Korea University Anam Hospital | |
| HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. | NCT00412022 | Breast Cancer | tamoxifen triptorelin letrozole zoledronic acid | 18 Years - | National Cancer Institute, Naples | |
| Overcoming Endocrine Resistance in Metastatic Breast Cancer | NCT02394496 | Metastatic Brea... | Fulvestrant Lapatinib Aromatase Inhib... Placebo Lapatin... | 18 Years - | Consorzio Oncotech | |
| Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment | NCT00241046 | Metastatic Brea... | Letrozole | 18 Years - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
